Medicare Part D coverage · potassium chloride · RxCUI 314182
potassium chloride 2.67 MEQ/ML Oral Solution
Per the CMS 2026 Part D formulary file, potassium chloride 2.67 MEQ/ML Oral Solution is covered by 4,895 Medicare Part D plans (96.9% of enrollable products), averaging Tier 2.8, with prior authorization required on 0% of covering formularies.
- 96.9%
- Plan coverage
- 4,895
- Plans covering
- T2.8
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for potassium chloride 2.67 MEQ/ML Oral Solution
Per the CMS 2026 Part D formulary file, potassium chloride 2.67 MEQ/ML Oral Solution (RxNorm concept RXCUI 314182, generic name potassium chloride) appears on 315 distinct formulary files spanning 4,895 Medicare Part D plan offerings - 96.9% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.8.
Real-world access to potassium chloride 2.67 MEQ/ML Oral Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,479,756 Part D beneficiaries filled potassium chloride 2.67 MEQ/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $396,019,205 and an average per-beneficiary annual cost of $113.81. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry potassium chloride 2.67 MEQ/ML Oral Solution today.
Coverage Details
- Formularies covering
- 315
- Plans covering
- 4,895
- Coverage rate
- 96.9%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,479,756
- Total spending
- $396,019,205
- Avg per beneficiary
- $113.81
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering potassium chloride 2.67 MEQ/ML Oral Solution
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | No | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | No | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | No | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | No | $0 | CA |
| Anthem Full Dual Advantage (HMO D-SNP) | Anthem Insurance Companies, Inc. | T1 | No | $0 | IN |
| Anthem I PathWays Dual Care Advantage (HMO D-SNP) | Anthem Insurance Companies, Inc. | T1 | No | $0 | IN |
| Anthem I PathWays Dual Care Advantage NFLOC (HMO D-SNP) | Anthem Insurance Companies, Inc. | T1 | No | $0 | IN |
| Wellpoint Full Dual Advantage (HMO-POS D-SNP) | Wellpoint Iowa, Inc. | T1 | No | $0 | IA |
| Wellpoint Full Dual Advantage 2 (HMO-POS D-SNP) | Wellpoint Iowa, Inc. | T1 | No | $0 | IA |
| Wellpoint Full Dual Advantage (HMO D-SNP) | Wellpoint West Virginia , Inc. | T1 | No | $0 | WV |
| Wellpoint Full Dual Advantage (HMO D-SNP) | Wellpoint Washington, Inc. | T1 | No | $0 | WA |
| Wellpoint Dual Advantage (HMO D-SNP) | Wellpoint Washington, Inc. | T1 | No | $0 | WA |
| Healthy Blue Dual Advantage (HMO D-SNP) | Community Care Health Plan OF Louisiana, Inc. | T1 | No | $0 | LA |
| Healthy Blue Dual Advantage 2 (HMO D-SNP) | Community Care Health Plan OF Louisiana, Inc. | T1 | No | $0 | LA |
| Anthem Dual Advantage (PPO D-SNP) | Anthem Insurance Companies, Inc. | T1 | No | $0 | VA |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Texas, Inc. | T1 | No | $0 | TX |
| Wellpoint Kidney Care (HMO-POS C-SNP) | Wellpoint Texas, Inc. | T1 | No | $0 | TX |
| Wellpoint Dual Advantage 2 (HMO D-SNP) | Wellpoint Texas, Inc. | T1 | No | $0 | TX |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is potassium chloride 2.67 MEQ/ML Oral Solution covered by Medicare Part D?
Yes, potassium chloride 2.67 MEQ/ML Oral Solution is covered by 4,895 Medicare Part D plans (96.9% of all Part D formularies).
What tier is potassium chloride 2.67 MEQ/ML Oral Solution on Medicare Part D plans?
potassium chloride 2.67 MEQ/ML Oral Solution averages Tier 2.8 across Part D plans, ranging from Tier 1 to Tier 4.
Does potassium chloride 2.67 MEQ/ML Oral Solution require prior authorization?
0% of Part D formularies require prior authorization for potassium chloride 2.67 MEQ/ML Oral Solution. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on potassium chloride 2.67 MEQ/ML Oral Solution?
In 2023, total Medicare Part D spending on potassium chloride 2.67 MEQ/ML Oral Solution was $396,019,205, covering 3,479,756 beneficiaries. The average spend per beneficiary was $113.81.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA